Internal Tissue Sealants Market

Internal Tissue Sealants Market: Overview

The Internal Tissue Sealants Market is valued at USD 6.8 Bn in 2026 and is projected to reach USD 11.4 Bn, growing at a CAGR of 8% by 2033. The growing demand for surgical services and the growing interest in reducing surgical wounds are factors influencing the expansion of this market. The amount of procedures performed on a global scale has dramatically increased. The WHO estimates that 235 million major surgical procedures are performed annually around the globe. The danger of tissue injury, severe bleeding, or wound infection is typically present throughout surgical treatments. Additionally, individuals with diabetes need extra caution because they are far more likely to experience complications before and after surgery. ATV, moped, and minibike injuries were 230,000; a skateboard, scooter, and hoverboard injuries totaled 218,000. Therefore, it is anticipated that an increase in injuries will fuel global demand for surgical sealants and adhesives.

Healthcare in poor nations is changing quickly. These nations' expanding populations will probably result in higher demand for medical equipment. Nearly two-thirds of the increase in spending was caused by the rising cost of illnesses and cutting-edge medical procedures. Healthcare spending is anticipated to rise in nations like China and India during the projection period. The World Economic Forum estimates that by 2022, emerging economies will be responsible for one-third of all global health expenditures. Certain healthcare investments offer enticing long-term financial advantages. Medical care is one area where people typically spend more as their income rises.

As the number of surgeries rises, so do intensive R&D efforts to expand the use of internal tissue sealants and adhesives. Sutures and staples are common substitutes for internal tissue sealants, but due to their superior ability to close wounds with little blood loss, surgical sealants and adhesives are predicted to take their place. The sealants don't need to be removed and make surgeries less uncomfortable.

Internal Tissue Sealants Market: COVID-19 Impact

The pandemic had an impact on how certain surgical procedures operated. For surgeons to continue offering their patients safe and effective care during the COVID-19 epidemic, precise regulations specific to each specialty must be developed and followed. With the regulatory authorities' strict instructions to avoid all non-emergent surgeries, the number of surgeries dramatically decreased during the pandemic, which impacted the purchase of internal tissue sealants and adhesives in surgical centers. The number of surgeries has dropped, and the surgeries have been postponed. With the drop in surgical procedures, there was also a decline in the need for internal tissue adhesives and sealants.

Rise in Caesarean Instances to Drive Growth of Internal Tissue Sealants and Adhesives

The rate of population growth in the world is unparalleled. Additionally, the quantity of cesarean (C-Section) operations is increasing. To support the main point, the WHO reports that 1 in every 5 births worldwide occurs via cesarean section. The cesarean procedure will be performed for nearly 29% of births, and the numbers are expected to increase. As a result, a growth of 8% throughout the period may be shown. By 2030, if current trends continue, Latin America and the Caribbean will deliver 53% of babies via C-section, Eastern Asia will deliver 63% of babies via C-section, and North Africa, Southern Europe, and Oceania will each contribute about 50% of babies via C-section. Surgical sealants must be used during a C-section to stop bleeding and subsequent infections.

Rising Incidence of Fatal Traffic Accidents to Help Market For Internal Tissue Sealants to Grow

According to information from the US Department of Transportation, 33,244 people killed in vehicle accidents required prompt medical attention and surgery in 2019. This represents an 11% increase from 2013. Similarly, the need for surgery following a crash is very common in low- and middle-income nations like India. India was responsible for 4,51,361 wounds and injuries, which is 4% more than in 2014, necessitating immediate medical attention or surgery to close the wounds. Sealants and adhesives are typically utilized in fatal auto accidents because the skin tears, and it becomes necessary to stop the blood from escaping the body.

Use of Too Many Chemicals in the Manufacturing of Adhesives and Sealants is Limiting Market Growth

Adhesives and sealants produce large amounts of chemical gases, which are dangerous and unhealthy to breathe. As a result, the rules governing their use are getting harsher. Moreover, producers are increasingly concerned about the growing customer knowledge of environmental and health issues. The regulatory environment is posing serious hurdles for the business. The U.S. Environmental Protection Agency and other environmental protection organizations are taking new actions and putting more barriers and limitations in the way of businesses.

Internal Tissue Sealants Market: Segment Overview

Fibrin-based Sealant to Dominate Market due to Its Increased Speed of Blood Clotting

Through the reaction of thrombin and fibrinogen at the site of the wound to create a cross-linked fibrin clot that stops bleeding, fibrin sealants recreate the last stage of the blood coagulation cascade. When controlling bleeding with conventional surgical procedures is difficult or impossible, these products are typically recommended as an addition to hemostasis. Compared to conventional hemostasis techniques, fibrin sealants reduce bleeding after total knee arthroplasty (TKA) and can be utilized to create hemostasis in a TKA lesion. TISSEEL and ARTISS (Baxter Healthcare Corp.), EVICEL (Omrix Biopharmaceuticals, Ltd., a Johnson & Johnson firm), and RAPLIXA are a few of the fibrin sealants with FDA approval (ProFibrix, BV. [The Medicines Company]). The benefits of using fibrin sealants, such as better patient outcomes, fewer problems, and decreased mortality risks, are expected to drive the segment's expansion over the projected period.

With Increase in Number of Surgeries, Hospitals to Dominate Market

In the forecast period, hospitals held a disproportionately large portion of the end-user market. It is due to the difficulties and emergency services offered by a hospital. Appendicitis cases are only discovered by patients when the pain becomes severe, and because they are unclear of the cause, they rush to the nearest hospitals for care. Accident cases frequently necessitate surgical intervention by an orthopedic surgeon or a neurosurgeon, similar to general surgery cases. Wounds must be stitched up, and more procedures must be authorized and carried out as needed. A consequence of the epidemic was the increase in hospitals.

North America to Acquire Largest Major Market Share due to Rising Cases of Surgical Injuries

Throughout the entire projection period, North America is anticipated to lead the market as a whole. The United States has the biggest market share in the North American area, which can be attributed to improved surgical device regulations and rising public awareness of the need for such treatments in the event of accidents and problems with chronic diseases. The National Safety Council (NSC) reports that in July 2021, there were 341,000 football injuries, 500,000 basketball player injuries, 457,000 bicycle injuries, and 526,000 injuries related to personal activity. 199,000 swimming-related injuries were addressed in emergency rooms, according to NSC. Over 50% of these overall injuries were to the knee, shoulder, head, and spine. As a result, the market under study is boosted by an increase in the number of injuries that require medical attention.

Additionally, according to the Center for Disease Control and Prevention, in 2020, approximately 600,000 American women will get hysterectomy procedures, approximately 460,000 will undergo cholecystectomy procedures, and approximately 1.3 million will elect to deliver their babies through C-sections. Since surgical scissors are needed for each of these procedures, the market in the nation is expanding. As a result of the aforementioned factors, the market is anticipated to have considerable expansion during the forecast period.

The Asia Pacific is anticipated to have considerable growth throughout the projected period because of the ongoing transition of healthcare delivery systems to cutting-edge value-based healthcare practices that build a sustainable health system. This will encourage the employment of cutting-edge procedures in operations and other medical procedures while enabling consumers to access better facilities at lower costs. According to the health care index, 5 of the top 10 nations are in Asia-Pacific. With better assistance from healthcare policymakers and government backing for infrastructure, the nations that were not on the list are now gaining ground. Similarly, hernia surgery in the North American region can cost up to $7,750, while it is only close to $1,000 in the Asia-Pacific region.

In December 2021, BD (Becton, Dickinson and Company), a leading worldwide medical technology company, announced today the acquisition of Tissuemed, Ltd., a privately held corporation headquartered in Leeds, England that is an industry leader in manufacturing self-adhesive surgical sealant films. Tissuemed, Ltd.'s acquisition increases BD's global options for surgeons outside the United States. In November 2020, TISSIUM, a privately held MedTech startup developing biomorphic programmable polymers for tissue restoration, announced today that it had acquired FDA approval. Food and Drug Administration for its application for an Investigational Device Exemption for its vascular sealant. TISSIUM's vascular sealant addresses the problem of obtaining hemostasis fast and avoiding post-operative bleeding after peripheral vascular procedures while also providing biocompatibility and a straightforward preparation and application technique for surgeons.

Few of the players in the Internal Tissue Sealants Market include:

• Baxter International Inc.
• Johnson & Johnson / Ethicon
• B. Braun SE
• Integra LifeSciences Holdings Corporation
• Medtronic plc
• BD / C. R. Bard
• CryoLife, Inc. / Artivion, Inc.
• CSL Behring
• TELA Bio, Inc.
• Advanced Medical Solutions Group plc
• Pfizer Inc.
• Terumo Corporation
• Stryker Corporation
• Cohera Medical, Inc.
• Vivostat A/S

The Global Internal Tissue Sealants Market is Segmented as Below:

By Product Type

• Rapid-acting Insulin Biosimilars
• Short-acting Insulin Biosimilars
• Intermediate-acting Insulin Biosimilars
• Long-acting Insulin Biosimilars
• Premixed Insulin Biosimilars

By Disease Type

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

By Delivery Device

• Insulin Pens
• Insulin Syringes
• Insulin Pumps
• Cartridges
• Vials

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Diabetes Clinics

By End User

• Hospitals
• Clinics
• Homecare Settings
• Ambulatory Care Centers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa